THC Farmaceuticals, Inc.
CBDG
Rank in Stocks
#33828
THC Farmaceuticals, Inc. specializes in the ownership and operation of... THC Farmaceuticals, Inc. specializes in the ownership and operation of independent (non-bank) automated teller machines (ATMs), strategically placing them within third-party retail and commercial establishments. These cash-dispensing units are typically situated in bustling commercial spaces such as hotels, stores, and bowling alleys, aiming for high customer footfall areas that often serve small and medium-sized enterprises. By mid-2015 (June 30), the company reported a network of eight public-access ATMs concentrated in Utah's Wasatch Front region. Founded in 2008 and based in Scottsdale, Arizona, the company adopted its current name, THC Farmaceuticals, Inc., in February 2015, having previously operated as City Media, Inc. THC Farmaceuticals, Inc. functions as a subsidiary of Weed Growth Fund, Inc.
Share Price
$0.009
Last synced: 2026-11-10
Market Cap
$163.18K
Change (1 day)
0.00%
Change (1 year)
-88.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade THC Farmaceuticals, Inc. (CBDG)
Category
Healthcare
EPS for THC Farmaceuticals, Inc. (CBDG)
EPS as of June 2022 TTM: $0.00
According to THC Farmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2023 EPS of 0.00.
EPS history for THC Farmaceuticals, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -100.00% |
| 2025 | 0.00 | -100.00% |
| 2023 | 0.00 | -103.40% |
| 2022 | $0.02 | -4,800.00% |
| 2021 | 0.00 | -86.11% |
| 2020 | 0.00 | -88.00% |
| 2019 | $-0.03 | 2,900.00% |
| 2018 | 0.00 | 100.00% |
| 2017 | 0.00 | -94.44% |
| 2016 | $-0.01 | 164.71% |
| 2014 | 0.00 | 25.93% |
| 2013 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -3,132,100.00% |
US
|
|
| $-7.07 | 1,413,900.00% |
US
|
|
| $-5.29 | 1,057,900.00% |
AU
|
|
| $12.88 | -2,576,120.00% |
BE
|
|
| $21.56 | -4,312,100.00% |
NL
|
Questions about THC Farmaceuticals, Inc.'s earnings per share (EPS)
What is THC Farmaceuticals, Inc.'s earnings per share (EPS)?
THC Farmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2022.
What was THC Farmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, THC Farmaceuticals, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2023.
How has THC Farmaceuticals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, THC Farmaceuticals, Inc.'s earnings per share (EPS) was highest in 2022 ($0.02) and lowest in 2025 (0.00).
How does THC Farmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
THC Farmaceuticals, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.